| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Neurobiology, Departments of Neurology and Psychiatry, University of Göttingen, Germany.
We determined the cytokine messenger RNA (mRNA) expression pattern of blood mononuclear cells in 45 patients with the relapsing-remitting form of MS and 32 patients with other neurologic diseases. Using a semiquantitative polymerase chain reaction method, we detected significantly higher levels of tumor necrosis factor-alpha and lymphotoxin mRNA in patients with relapsing compared to those with stable disease (p < 0.001), but transforming growth factor-beta and interleukin-10 mRNA expressions were higher in patients with stable disease.
Address correspondence and reprint requests to Dr. P. Rieckmann, Department of Neurology, University of Göttingen, Robert Koch Str. 40, 37075 Göttingen, Germany.
Supported by grants from the Hertie-Stiftung (GHS 204/91), Deutsche Multiple Sklerose Gesellschaft and Deutsche Forschungsgemeinschaft (DFG Az Ri 516-2/1).
Received November 15, 1993. Accepted in final form February 1, 1994.
This article has been cited by other articles:
|
|
 |
|
  K. Hamamcioglu and A. Reder Interferon-{beta} regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis Multiple Sclerosis, May 1, 2007; 13(4): 459 - 470. [Abstract] [PDF]
|
|
|
|
 |
|
 K. M. Spach, F. E. Nashold, B. N. Dittel, and C. E. Hayes IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2006; 177(9): 6030 - 6037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ishizu, M. Osoegawa, F.-J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis Brain, May 1, 2005; 128(5): 988 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Feng, T. Misu, K. Fujihara, S. Sakoda, Y. Nakatsuji, H. Fukaura, S. Kikuchi, K. Tashiro, A. Suzumura, N. Ishii, et al. Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis Multiple Sclerosis, October 1, 2004; 10(5): 494 - 498. [Abstract] [PDF]
|
|
|
|
|
|
P. Flachenecker, I. Bihler, F Weber, M Gottschalk, K. V Toyka, and P. Rieckmann Cytokine mRNA expression in patients with multiple sclerosis and fatigue Multiple Sclerosis, April 1, 2004; 10(2): 165 - 169. [Abstract] [PDF]
|
|
|
|
|
|
A. Minagar and J S. Alexander Blood-brain barrier disruption in multiple sclerosis Multiple Sclerosis, December 1, 2003; 9(6): 540 - 549. [Abstract] [PDF]
|
|
|
|
|
|
V Ozenci, M Kouwenhoven, and H Link Cytokines in multiple sclerosis: methodological aspects and pathogenic implications Multiple Sclerosis, October 1, 2002; 8(5): 396 - 404. [Abstract] [PDF]
|
|
|
|
|
|
N. K. U. Koehler, C. P. Genain, B. Giesser, and S. L. Hauser The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study J. Immunol., June 1, 2002; 168(11): 5920 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Killestein, M. H.G. Rep, J. F. Meilof, H. J. Ader, B. M.J. Uitdehaag, F. Barkhof, R. A.W. van Lier, and C. H. Polman Seasonal variation in immune measurements and MRI markers of disease activity in MS Neurology, April 9, 2002; 58(7): 1077 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Walker and S. B Margolin Pirfenidone for chronic progressive multiple sclerosis Multiple Sclerosis, October 1, 2001; 7(5): 305 - 312. [Abstract] [PDF]
|
|
|
|
|
|
P. M. da Costa, C. L. Yasuda, S. M Scagliusi, B. M. Diaz-Bardales, E. Maciel, B. P Damasceno, M H. S. Blotta, C. P Tilbery, and L. M. Santos pattern of cytokine secretion by peripheral blood cells of patients with multiple sclerosis in Brazil Multiple Sclerosis, October 1, 2000; 6(5): 293 - 299. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Pelfrey, R. A. Rudick, A. C. Cotleur, J.-C. Lee, M. Tary-Lehmann, and P. V. Lehmann Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production J. Immunol., August 1, 2000; 165(3): 1641 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Rohowsky-Kochan, D Molinaro, and S D Cook Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis Multiple Sclerosis, April 1, 2000; 6(2): 69 - 77. [Abstract] [PDF]
|
|
|
|
|
|
B. A. Kallmann, V. Hummel, T. Lindenlaub, K. Ruprecht, K. V. Toyka, and P. Rieckmann Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1 Brain, April 1, 2000; 123(4): 687 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kracke, P. von Wussow, A. N. Al-Masri, G. Dalley, A. Windhagen, and F. Heidenreich Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS Neurology, January 11, 2000; 54(1): 193 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bourrie, E. Bribes, M. Esclangon, L. Garcia, J. Marchand, C. Thomas, J.-P. Maffrand, and P. Casellas The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment PNAS, October 26, 1999; 96(22): 12855 - 12859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Jurewicz, A. K. Walczak, and K. W. Selmaj Shedding of TNF receptors in multiple sclerosis patients Neurology, October 22, 1999; 53(7): 1409 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Arnason TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study Neurology, August 1, 1999; 53(3): 457 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Monteyne and C. J. Sindic Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR Multiple Sclerosis, June 1, 1998; 4(3): 143 - 146. [Abstract] [PDF]
|
|
|
|
|
|
A. T Reder, K. Genc, P. V Byskosh, and A. M. Porrini Monocyte activation in multiple sclerosis Multiple Sclerosis, June 1, 1998; 4(3): 162 - 168. [Abstract] [PDF]
|
|
|
|
|
|
M. Chofflon and B. Fellay Monitoring Multiple Sclerosis course and activity with TNF-alpha Multiple Sclerosis, June 1, 1998; 4(3): 188 - 192. [PDF]
|
|
|
|
|
|
M. Schluep, G. van Melle, H. Henry, C. Stadler, B. Roth-Wicky, and P. J Magistretti In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis Multiple Sclerosis, June 1, 1998; 4(3): 198 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 B. W. van Oosten, F. Barkhof, P. E. T. Scholten, B. M. E. von Blomberg, H. J. Ader, and C. H. Polman Increased Production of Tumor Necrosis Factor {alpha}, and Not of Interferon {gamma}, Preceding Disease Activity in Patients With Multiple Sclerosis Arch Neurol, June 1, 1998; 55(6): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Link The cytokine storm in multiple sclerosis Multiple Sclerosis, February 1, 1998; 4(1): 12 - 15. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Creange, L. Belec, B. Clair, J.-D. Degos, J.-C. Raphael, and R. K Gherardi Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 162 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ferrante, M. L. Fusi, M. Saresella, D. Caputo, M. Biasin, D. Trabattoni, A. Salvaggio, E. Clerici, J. E. de Vries, G. Aversa, et al. Cytokine Production and Surface Marker Expression in Acute and Stable Multiple Sclerosis: Altered IL-12 Production and Augmented Signaling Lymphocytic Activation Molecule (SLAM)-Expressing Lymphocytes in Acute Multiple Sclerosis J. Immunol., February 1, 1998; 160(3): 1514 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Durelli, M. Bongioanni, B Ferrero, D Imperiale, E Verdun, A Oggero, E Gentile, G. Bradac, M Bergui, L Bergamini, et al. Long term recombinant interferon alpha treatment in MS with special emphasis to side effects Multiple Sclerosis, June 1, 1996; 1(6): 366 - 371. [Abstract] [PDF]
|
|
|
|
|
|
R. Hohlfeld Inhibitors of tumor necrosis factor-{alpha}: Promising agents for the treatment of multiple sclerosis? Multiple Sclerosis, June 1, 1996; 1(6): 376 - 378. [Abstract] [PDF]
|
|
|
|
|
|
P. Byskosh and A. Reder Interferon {beta}-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis Multiple Sclerosis, April 1, 1996; 1(5): 262 - 269. [Abstract] [PDF]
|
|
|
|
|
|
M Soderstrom, J Hillert, J Link, V Navikas, S Fredrikson, and H Link Expression of IFN-{gamma}, IL-4, and TGF-{beta} in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease Multiple Sclerosis, November 1, 1995; 1(3): 173 - 180. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
